ORMP
Price
$2.25
Change
+$0.05 (+2.27%)
Updated
Dec 7, 6:59 PM EST
82 days until earnings call
VXRT
Price
$0.70
Change
+$0.01 (+1.45%)
Updated
Dec 7, 6:59 PM EST
76 days until earnings call
Ad is loading...

Compare trend and price ORMP vs VXRT

Header iconORMP vs VXRT Comparison
Open Charts ORMP vs VXRTBanner chart's image
Oramed Pharmaceuticals
Price$2.25
Change+$0.05 (+2.27%)
Volume$91.08K
CapitalizationN/A
Vaxart
Price$0.70
Change+$0.01 (+1.45%)
Volume$229.29K
CapitalizationN/A
View a ticker or compare two or three
ORMP vs VXRT Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ORMP vs. VXRT commentary
Dec 08, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and VXRT is a Hold.

COMPARISON
Comparison
Dec 08, 2023
Stock price -- (ORMP: $2.26 vs. VXRT: $0.70)
Brand notoriety: ORMP and VXRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 72% vs. VXRT: 47%
Market capitalization -- ORMP: $88.75M vs. VXRT: $111.95M
ORMP [@Biotechnology] is valued at $88.75M. VXRT’s [@Biotechnology] market capitalization is $111.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 1 FA rating(s) are green whileVXRT’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 1 green, 4 red.
  • VXRT’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than VXRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 7 TA indicator(s) are bullish while VXRT’s TA Score has 3 bullish TA indicator(s).

  • ORMP’s TA Score: 7 bullish, 2 bearish.
  • VXRT’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than VXRT.

Price Growth

ORMP (@Biotechnology) experienced а +1.80% price change this week, while VXRT (@Biotechnology) price change was -2.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10152.36%. For the same industry, the average monthly price growth was +6.66%, and the average quarterly price growth was +25.39%.

Reported Earning Dates

ORMP is expected to report earnings on Feb 28, 2024.

VXRT is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+10152.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ORMP with price predictions.
OPEN
A.I.dvisor published
a Summary for VXRT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VXRT($112M) has a higher market cap than ORMP($88.7M). VXRT YTD gains are higher at: -27.464 vs. ORMP (-81.214). ORMP has higher annual earnings (EBITDA): -15.96M vs. VXRT (-79.83M). ORMP has more cash in the bank: 175M vs. VXRT (52.2M). VXRT has less debt than ORMP: VXRT (20.5M) vs ORMP (76M). ORMP has higher revenues than VXRT: ORMP (2.02M) vs VXRT (776K).
ORMPVXRTORMP / VXRT
Capitalization88.7M112M79%
EBITDA-15.96M-79.83M20%
Gain YTD-81.214-27.464296%
P/E RatioN/AN/A-
Revenue2.02M776K260%
Total Cash175M52.2M335%
Total Debt76M20.5M371%
FUNDAMENTALS RATINGS
ORMP vs VXRT: Fundamental Ratings
ORMP
VXRT
OUTLOOK RATING
1..100
1481
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9398
PRICE GROWTH RATING
1..100
6572
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (33) in the Pharmaceuticals Other industry is in the same range as VXRT (55) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VXRT’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as VXRT (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VXRT’s over the last 12 months.

ORMP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as VXRT (98) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VXRT’s over the last 12 months.

ORMP's Price Growth Rating (65) in the Pharmaceuticals Other industry is in the same range as VXRT (72) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VXRT’s over the last 12 months.

ORMP's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as VXRT (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to VXRT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPVXRT
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 16 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOF0.08N/A
+4.43%
Blue Biofuels
MSOCX20.530.16
+0.79%
Morgan Stanley Inst International Opp C
EISAX20.620.10
+0.49%
Carillon ClariVest Intl Stock A
YAFIX19.80N/A
N/A
AMG Yacktman Focused I
PEGRY18.80-0.18
-0.95%
Pennon Group plc

VXRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VXRT has been loosely correlated with MDGL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if VXRT jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VXRT
1D Price
Change %
VXRT100%
+1.71%
MDGL - VXRT
62%
Loosely correlated
-0.56%
AXON - VXRT
50%
Loosely correlated
+1.29%
ARRY - VXRT
48%
Loosely correlated
+0.38%
ORMP - VXRT
47%
Loosely correlated
+2.73%
SANA - VXRT
46%
Loosely correlated
+1.17%
More